Providence Cancer Center: Commitment to immunotherapy

July 14, 2017
Providence is one of 10 leading international research institutions joining in a Bristol-Myers Squibb collaboration that will focus on helping the body’s own immune system fight cancer.
Previous Video
Clinical Trial Patient Comments
Clinical Trial Patient Comments

SBRT/IL-2 research and clinical trial patient comments

Next Video
Providence Cancer Center: Flow cytometry
Providence Cancer Center: Flow cytometry

Providence Cancer Center researchers are recognized around the world for their work with flow cytometry, or...